GRAINGER DAVID J 4
4 · Centessa Pharmaceuticals plc · Filed Feb 3, 2022
Insider Transaction Report
Form 4
GRAINGER DAVID J
Chief Innovation Officer
Transactions
- Award
Share Option (right to buy)
2022-02-01+200,000→ 200,000 totalExercise: $9.53Exp: 2032-02-01→ Ordinary Shares (200,000 underlying)
Footnotes (2)
- [F1]33,328 shares subject to such option shall vest and become exercisable on October 1,2022 and the remaining 166,672 shares subject to such option shall vest and become exercisable in 40 substantially equal installments on each monthly anniversary thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.